Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[mdropp]

Dr. Ladenson NOT in violation of John Hopkin's policy.

"Kim Hoppe, another spokesperson for Johns Hopkins, told MedPage Today on Wednesday that the quote turned out not to be in violation of university policy at the time."

"In Feuerstein's article for The Street, Johns Hopkins spokesperson Stephanie Desmond said Ladenson's quote in the Jan. 7 press release was in violation of Hopkins policy and that the university had opened an inquiry into the matter."

http://www.medpagetoday.com/Endocrinology/GeneralEndocrinology/43942

The ridiculous lawsuit will be thrown out as Hopkin's also continues to display the anatabine study on their website.

Even though Landenson was a paid consultant, Hopkin's knows about and did support his research as evidenced by their website support and study inquires to be made to Hopkin's e-mail address.